In:
US Cardiology Review, Radcliffe Media Media Ltd, ( 2017), p. 1-
Kurzfassung:
Recently it has become more apparent that microvascular dysfunction is responsible for morbidity and mortality in many different cardiovascular diseases. It is no longer felt to be benign, and besides accounting for angina symptoms, it likely plays a role in heart failure with preserved ejection fraction, as well as in Takotsubo syndrome and various inflammatory diseases associated with ischemia and atherosclerosis. Coronary microvascular disease can be diagnosed by means of invasive coronary reactivity testing and noninvasively by echocardiography, computerized tomography, magnetic resonance, and positron emission tomography. Unfortunately, treatment has been more empiric, and not as well evaluated by randomized trials as in other disease states. Beta blockers, nitrates, and calcium channel blockers have all been used with varying degrees of success. Given its prevalence, particularly among women, its increased recognition and importance mandates further research into prompt diagnosis and more robust studies of its treatment.
Materialart:
Online-Ressource
ISSN:
1758-3896
DOI:
10.15420/usc.2017:27:1
Sprache:
Englisch
Verlag:
Radcliffe Media Media Ltd
Publikationsdatum:
2017
ZDB Id:
3017967-1
Permalink